ArticleGenes and immunity2020

Diversity of KIRs in invasive breast cancer patients and healthy controls along with the clinical significance in ER/PR/HER2+ patients.

Marjan Hematian Larki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.